Literature DB >> 17207961

Hepatic veno-occlusive disease after neoadjuvant treatment of colorectal liver metastases with oxaliplatin: a lesson of the month.

A P Schouten van der Velden1, C J A Punt, J H J Van Krieken, V A Derleyn, T J M Ruers.   

Abstract

A patient is presented who was treated with neoadjuvant oxaliplatin-based chemotherapy followed by hepatic resection complicated by fatal liver failure. Histopathological examination revealed hepatic veno-occlusive disease, which is an infrequent reported side effect of oxaliplatin.

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17207961     DOI： 10.1016/j.ejso.2006.11.022

Source DB:  PubMed          Journal:  Eur J Surg Oncol        ISSN： 0748-7983            Impact factor:   4.424


  2 in total

Review 1.  [Steatohepatitis after chemotherapy for colorectal liver metastases (CASH)].

Authors:  A Tannapfel; A Reinacher-Schick; B Flott-Rahmel
Journal:  Pathologe       Date:  2011-07       Impact factor: 1.011

2.  Comparison Between Liver Stiffness Measurement by Fibroscan and Splenic Volume Index as NonInvasive Tools for the Early Detection of Oxaliplatin-induced Hepatotoxicity.

Authors:  Youssef Bouferraa; Yolla Haibe; Elio Jabra; Maya Charafeddine; Malek Kreidieh; Randa Raad; Sally Temraz; Deborah Mukherji; Firas Ershaid; Nadim Muallem; Walid Faraj; Mohamad Khalife; Rania A Eid; Ali Shamseddine
Journal:  J Clin Exp Hepatol       Date:  2021-06-15
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.